These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8103253)

  • 1. Effects of systemic isotretinoin on serum markers of collagen synthesis and degradation.
    Autio P; Risteli J; Palatsi R; Väänänen K; Vuori J; Risteli L; Oikarinen A
    Acta Derm Venereol; 1993 Apr; 73(2):108-12. PubMed ID: 8103253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
    Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen.
    Oikarinen A; Autio P; Vuori J; Väänänen K; Risteli L; Kiistala U; Risteli J
    Br J Dermatol; 1992 Feb; 126(2):172-8. PubMed ID: 1536783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum markers of bone metabolism in multiple myeloma: prognostic value of the carboxy-terminal telopeptide of type I collagen (ICTP). Nordic Myeloma Study Group (NMSG).
    Abildgaard N; Bentzen SM; Nielsen JL; Heickendorff L
    Br J Haematol; 1997 Jan; 96(1):103-10. PubMed ID: 9012695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
    Sartorio A; Conti A; Monzani M
    Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation.
    Yasumizu T; Kato J
    Endocr J; 1996 Apr; 43(2):191-5. PubMed ID: 8793335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of serologic markers for collagen synthesis and degradation in systemic sclerosis.
    Heickendorff L; Zachariae H; Bjerring P; Halkier-Sørensen L; Søndergaard K
    J Am Acad Dermatol; 1995 Apr; 32(4):584-8. PubMed ID: 7896946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.
    Kjeldsen J; Schaffalitzky de Muckadell OB; Junker P
    Gut; 1995 Dec; 37(6):805-10. PubMed ID: 8537052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.
    Conti A; Sartorio A; Ferrero S; Ferrario S; Ambrosi B
    J Endocrinol Invest; 1996 Feb; 19(2):127-30. PubMed ID: 8778165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].
    Sartorio A; Conti A; Monzani M; Ferrero S; Biella O; Casati G; Faglia G
    Minerva Endocrinol; 1995 Jun; 20(2):135-40. PubMed ID: 8531895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupuytren's disease in type I diabetic subjects: investigation of biochemical markers of type III and I collagen.
    Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
    Clin Exp Rheumatol; 2000; 18(2):215-9. PubMed ID: 10812494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal serum indices of bone collagen biosynthesis and degradation in small for gestational age infants.
    Namgung R; Tsang RC; Sierra RI; Ho ML
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):224-8. PubMed ID: 8890070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased degradation of type I collagen in patients with inflammatory bowel disease.
    Silvennoinen J; Risteli L; Karttunen T; Risteli J
    Gut; 1996 Feb; 38(2):223-8. PubMed ID: 8801201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
    Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Szymańska A; Nahaczewska W
    Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum markers of type I collagen synthesis and degradation in amyotrophic lateral sclerosis.
    Ono S; Imai T; Shimizu N; Nakayama M; Yamano T; Tsumura M
    Eur Neurol; 2000; 44(1):49-56. PubMed ID: 10894996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal collagen turnover markers in intrauterine growth restriction.
    Gourgiotis D; Briana DD; Georgiadis A; Boutsikou M; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
    J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1719-22. PubMed ID: 22339296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum markers of collagen synthesis and degradation in skin diseases. Altered levels in diseases with systemic manifestation and during systemic glucocorticoid treatment.
    Autio P; Risteli J; Kiistala U; Risteli L; Karvonen J; Oikarinen A
    Arch Dermatol Res; 1993; 285(6):322-7. PubMed ID: 8215582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W; Muley T; Herb KP; Schmidt-Gayk H
    Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.
    Blomqvist C; Risteli L; Risteli J; Virkkunen P; Sarna S; Elomaa I
    Br J Cancer; 1996 May; 73(9):1074-9. PubMed ID: 8624266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.